Literature DB >> 19303379

Damage control surgery.

S S Jaunoo1, D P Harji.   

Abstract

The principles of trauma surgery have evolved during the past 20 years; from initial aggressive, definitive management of all surgical injuries in the traumatised patient to an abbreviated laparotomy, secondary correction of abnormal physiological parameters and then planned definitive re-exploration; the damage control sequence.

Entities:  

Mesh：

Year:  2009        PMID： 19303379     DOI： 10.1016/j.ijsu.2009.01.008

Source DB:  PubMed          Journal:  Int J Surg        ISSN： 1743-9159            Impact factor:   6.071


  5 in total

1.  Single-staged laparotomy versus multiple-staged laparotomy for traumatic massive hemoperitoneum with hemodynamic instability: a single-center, propensity score-matched analysis.

Authors:  Masaki Matsuda; Makoto Sawano
Journal:  BMC Surg       Date:  2022-06-02       Impact factor: 2.030

2.  [Damage control concept in liver trauma. Package strategies and secondary measures].

Authors:  F Rauchfuss; R Voigt; M Götz; M Heise; T Uberrück; U Settmacher
Journal:  Chirurg       Date:  2009-10       Impact factor: 0.955

3.  Controlled Delayed Aortic Repair in Acute Aortic Syndrome and Multiorgan Failure: An Option in Selected Cases.

Authors:  Daniel S Dohle; Konstantinos Tsagakis; Saifeldin Ibrahim; Björn Plicht; Heinz Jakob
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-01-20

4.  Recurring septic shock in a patient with blunt abdominal and pelvic trauma: how mandatory is source control surgery?: a case report.

Authors:  Antonella Frattari; Giustino Parruti; Rocco Erasmo; Luigi Guerra; Ennio Polilli; Rosamaria Zocaro; Giuliano Iervese; Paolo Fazii; Tullio Spina
Journal:  J Med Case Rep       Date:  2017-02-22

5.  Providing surgery in a war-torn context: the Médecins Sans Frontières experience in Syria.

Authors:  Miguel Trelles; Lynette Dominguez; Katie Tayler-Smith; Katrin Kisswani; Alberto Zerboni; Thierry Vandenborre; Silvia Dallatomasina; Alaa Rahmoun; Marie-Christine Ferir
Journal:  Confl Health       Date:  2015-12-15       Impact factor: 2.723
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.